Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katharina Hansel

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Dermatologic Therapy|October 22, 2021
Real-world evidence of biologic treatments in moderate-severe psoriasis in Italy: Results of the CANOVA (EffeCtiveness of biologic treAtmeNts for plaque psOriasis in Italy: An obserVAtional longitudinal study of real-life clinical practice) studyDelia Colombo, Luca Bianchi, Gabriella Fabbrocini, et al.
Paediatric Drugs|August 26, 2022
Dupilumab Treatment in Children Aged 6-11 Years With Atopic Dermatitis: A Multicentre, Real-Life StudyMaddalena Napolitano, Gabriella Fabbrocini, Iria Neri, et al.
BMC Health Services Research|September 7, 2021
A real-world economic analysis of biologic therapies for moderate-to-severe plaque psoriasis in Italy: results of the CANOVA observational longitudinal studyEmanuela Zagni, Luca Bianchi, Gabriella Fabbrocini, et al.
Plos One|August 14, 2020
Patients' demographic and socioeconomic characteristics influence the therapeutic decision-making process in psoriasisEmanuele Scala, Matteo Megna, Paolo Amerio, et al.
Dermatology Practical & Conceptual|April 14, 2025
Enhancing Skin Cancer Prevention and Awareness in the Italian Population: Insights from the "Save Your Skin" Screening CampaignPaola Savoia, Laura Cristina Gironi, Chiara Airoldi, et al.
Clinical and Molecular Allergy : CMA|May 12, 2020
Urticaria: recommendations from the Italian Society of Allergology, Asthma and Clinical Immunology and the Italian Society of Allergological, Occupational and Environmental DermatologyEustachio Nettis, Caterina Foti, Marina Ambrifi, et al.
Clinical and Molecular Allergy : CMA|December 21, 2021
Quality of life in patients with allergic and immunologic skin diseases: in the eye of the beholderEster Di Agosta, Lorenzo Salvati, Monica Corazza, et al.
Dermatology and Therapy|October 10, 2025
Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort StudyGianluca Avallone, Andrea Bombelli, Luigi Gargiulo, et al.
Clinical and Experimental Dermatology|July 15, 2025
Therapeutic Outcomes Across JAK Inhibitors in Prurigo NodularisGianluca Avallone, Andrea Bombelli, Luca Valtellini, et al.
Clinical and Experimental Dermatology|June 11, 2024
Short-, mid- and long-term efficacy of dupilumab in moderate-to-severe atopic dermatitis: a real-world multicentre Italian study of 2576 patientsSilvia Ferrucci, Simona Tavecchio, Carlo Alberto Maronese, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Dermatologic Therapy|October 22, 2021
Real-world evidence of biologic treatments in moderate-severe psoriasis in Italy: Results of the CANOVA (EffeCtiveness of biologic treAtmeNts for plaque psOriasis in Italy: An obserVAtional longitudinal study of real-life clinical practice) studyDelia Colombo, Luca Bianchi, Gabriella Fabbrocini, et al.
Paediatric Drugs|August 26, 2022
Dupilumab Treatment in Children Aged 6-11 Years With Atopic Dermatitis: A Multicentre, Real-Life StudyMaddalena Napolitano, Gabriella Fabbrocini, Iria Neri, et al.
BMC Health Services Research|September 7, 2021
A real-world economic analysis of biologic therapies for moderate-to-severe plaque psoriasis in Italy: results of the CANOVA observational longitudinal studyEmanuela Zagni, Luca Bianchi, Gabriella Fabbrocini, et al.
Plos One|August 14, 2020
Patients' demographic and socioeconomic characteristics influence the therapeutic decision-making process in psoriasisEmanuele Scala, Matteo Megna, Paolo Amerio, et al.
Dermatology Practical & Conceptual|April 14, 2025
Enhancing Skin Cancer Prevention and Awareness in the Italian Population: Insights from the "Save Your Skin" Screening CampaignPaola Savoia, Laura Cristina Gironi, Chiara Airoldi, et al.
Clinical and Molecular Allergy : CMA|May 12, 2020
Urticaria: recommendations from the Italian Society of Allergology, Asthma and Clinical Immunology and the Italian Society of Allergological, Occupational and Environmental DermatologyEustachio Nettis, Caterina Foti, Marina Ambrifi, et al.
Clinical and Molecular Allergy : CMA|December 21, 2021
Quality of life in patients with allergic and immunologic skin diseases: in the eye of the beholderEster Di Agosta, Lorenzo Salvati, Monica Corazza, et al.
Dermatology and Therapy|October 10, 2025
Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort StudyGianluca Avallone, Andrea Bombelli, Luigi Gargiulo, et al.
Clinical and Experimental Dermatology|July 15, 2025
Therapeutic Outcomes Across JAK Inhibitors in Prurigo NodularisGianluca Avallone, Andrea Bombelli, Luca Valtellini, et al.
Clinical and Experimental Dermatology|June 11, 2024
Short-, mid- and long-term efficacy of dupilumab in moderate-to-severe atopic dermatitis: a real-world multicentre Italian study of 2576 patientsSilvia Ferrucci, Simona Tavecchio, Carlo Alberto Maronese, et al.
Pageof 7